| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014700 Cbi analogues of cc-1065 and the duocarmycins |
| 01/20/2005 | US20050014650 Delta 1-pyrrolines used as pesticides |
| 01/20/2005 | US20050014278 Acid-labile isotope-coded extractant (ALICE) and its use in quantitative mass spectrometric analysis of protein mixtures |
| 01/20/2005 | US20050011411 Anthraquinone, xanthene dyes: coloring ink |
| 01/20/2005 | DE10329860A1 Sulfonamidderivate polycyclischer Farbstoffe für analytische Anwendungen Sulfonamide derivatives of polycyclic dyes for analytical applications |
| 01/20/2005 | CA2532056A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 01/20/2005 | CA2531757A1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 01/20/2005 | CA2531751A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 01/20/2005 | CA2530737A1 Cck-1 receptor modulators |
| 01/20/2005 | CA2530538A1 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | CA2530450A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | CA2530312A1 Arylamine-substituted quinazolinone compounds |
| 01/20/2005 | CA2528626A1 Indoles useful in the treatment of inflammation |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1498109A1 Furan derivatives and dyeing composition comprising a furan derivative as coupler |
| 01/19/2005 | EP1497298A1 Derivatives of 2,2,4-trisubstituted tetrahydrofuran as antifungal agents |
| 01/19/2005 | EP1497287A1 Quinolinone derivatives |
| 01/19/2005 | EP1497284A2 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors |
| 01/19/2005 | EP1497282A2 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4 protease |
| 01/19/2005 | EP1497279A2 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 01/19/2005 | EP1497240A1 Non-heating clay composites for building materials |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496894A1 Angiogenesis inhibitors |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/19/2005 | EP0958293B1 Nanomolar, non-peptide inhibitors of cathepsin d |
| 01/19/2005 | CN1568323A Activator for peroxisome proliferator-activated receptor delta |
| 01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1566098A Isoquinoline compound, preparation method and application of salt thereof |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566091A Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185228C Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/19/2005 | CN1185216C Fungicides |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/18/2005 | US6844441 Hypoglycemic agents; dietetics; gastrointestinal disorders; antidepressants; gastrointestinal disorders; antiinflammatory agents |
| 01/18/2005 | US6844437 Chemical intermediates; anticholesterol agents, antilipemic agents |
| 01/18/2005 | US6844344 Depression, anxiety; tobacco or nicotine withdrawal; such as 1-(benzofuran-4-yl)oxy-3-(4-(6-methoxybenzo(b)thiophen-2-yl)piperidinyl)-2 -propanol oxalate |
| 01/13/2005 | WO2005003131A1 Tricyclic delta opioid modulators |
| 01/13/2005 | WO2005003124A1 Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 01/13/2005 | WO2005003123A1 Novel pyridine derivatives as jnk specific inhibitors |
| 01/13/2005 | WO2005003122A1 5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides |
| 01/13/2005 | WO2005003121A1 Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 01/13/2005 | WO2005003103A2 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases |
| 01/13/2005 | WO2005003102A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 01/13/2005 | WO2005003101A2 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 01/13/2005 | WO2005003100A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 01/13/2005 | WO2005003099A2 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | WO2005003097A1 Cis-2,4,5-triaryl-imidazolines |
| 01/13/2005 | WO2005003086A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications |
| 01/13/2005 | WO2005002552A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 01/13/2005 | WO2004106329A3 Novel antiinfective compounds and their pharmaceutical compositions |
| 01/13/2005 | WO2004099192A3 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 01/13/2005 | WO2004072047A8 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | WO2004052883A3 Process for the separation of enantiomers |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050009900 3-Substituted with a heterocyclic group, e.g., 2-Chloro-5-[1-(2,3-dihydroxy-propyl)-5-methyl-1H-pyrazol-3-yl]-N-(1-hydroxy-cycloheptylmethyl)-benzamide; treatment of IL-1 mediated disorders, including osteo- and rheumatoid arthritis, allergies, asthma, COPD, cancer, and reperfusion or ischemia in stroke |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009892 Phenyloxazole derivatives lower blood triglyceride, glucose, insulin; hyperlipidemia, arteriosclerosis, diabetes mellitus, hypertension, obesity; 2-methyl-2-[6-(5-methyl-2-phenyloxazol-4-yl)-(E)-4-hexenyloxy]propionic acid |
| 01/13/2005 | US20050009876 Indazole compounds, compositions thereof and methods of treatment therewith |
| 01/13/2005 | US20050009870 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 01/13/2005 | US20050009867 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/13/2005 | US20050009864 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 01/13/2005 | US20050009860 Tricyclic delta-opioid modulators |
| 01/13/2005 | US20050009855 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives; these compounds interfere with the E1-E2-DNA complex during initiation of DNA replication |
| 01/13/2005 | US20050009853 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 01/13/2005 | US20050009850 Quinazoline compounds with therapeutic use |
| 01/13/2005 | US20050009844 Inhibitors of p38 |
| 01/13/2005 | US20050009840 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009819 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/13/2005 | US20050009818 Therapeutic heterocyclic compounds |
| 01/13/2005 | US20050009817 Substituted heteroaryls |
| 01/13/2005 | US20050009815 4-Aminoquinoline compounds |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | US20050009809 Acridine derivatives and their use as medicaments |
| 01/13/2005 | US20050009808 Azabicyclo compound matrix metalloprotease inibitor and skin preparation |
| 01/13/2005 | US20050009785 Heterocyclic compounds |
| 01/13/2005 | US20050009730 Sleep disorders; side effect reduction |
| 01/13/2005 | US20050009076 Conjugate of hormone (thyroxine) and inosine-5'-monophosphate dehydrogenase inhibitor (such as mycophenolic acid) |
| 01/13/2005 | US20050008968 Basic compound, resist composition and patterning process |
| 01/13/2005 | CA2531327A1 Compounds and therapeutical use thereof |
| 01/13/2005 | CA2531061A1 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | CA2531050A1 Pharmaceutical compounds |
| 01/13/2005 | CA2530389A1 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 01/13/2005 | CA2528119A1 Cis-2,4,5-triaryl-imidazolines |
| 01/12/2005 | EP1495757A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 01/12/2005 | EP1495040A1 Method for synthesizing beta-l-fluoro-2',3'didehydcytidine (beta-l-fd4c) |
| 01/12/2005 | EP1495018A1 Tricyclic thrombin receptor antagonists |
| 01/12/2005 | EP1495004A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands |
| 01/12/2005 | EP1495003A1 Fredericamycin derivatives |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1495001A1 Antibacterial agents |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |